search
Back to results

Interest of 2-octyl-cyanoacrylate (Dermabond®) in Closing Surgical Incisions in Children Before Acquisition of Continence

Primary Purpose

Inguinal Incisions

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
cutaneous suture (Surjet)
2-octyl-cyanoacrylate (Dermabond® glue)
Sponsored by
Centre Hospitalier Universitaire de Nice
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inguinal Incisions focused on measuring dermabond glue, suture, children

Eligibility Criteria

undefined - 24 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children less than 24 months old
  • Continuous nappies wearing for non-acquisition of continence
  • Need of a surgical intervention which entry way is an inguinal incision in the inguinal fold (POTTS incision) for the following indications:

    • inguinal hernia
    • testicular ectopy
    • hydrocele
    • chord cyst
  • Surgical incision smaller than 5 cm
  • Informed consent form signed by both parents or by the legal representative
  • Patient affiliated to French national health and pensions organization

Exclusion Criteria:

  • Chronic or acute dermatological affection that can hamper wound-healing (atopic pathology, infectious pathology…)
  • General affection that can hamper wound-healing (chronic denutrition)
  • Cutaneous infection at the incision site
  • Scar in the concerned region
  • Medical history of wound-healing trouble
  • Digestive pathology causing chronic or acute diarrhea
  • Allergy to one of the used compounds (glue, string, wound dressing)
  • Operative indication set in emergency with immediate surgery
  • Non-acceptance of the protocol, refusal to participate to the study by one of the parents or the legal representative
  • Impossibility of doing the follow up of the child, in accordance with the pre-established rules of the protocol

Sites / Locations

  • Centre Hospitalier Universitaire de Nice - Hôpital l'Archet2
  • Fondation Lenval -Hôpital Pédiatrique
  • Assistance Publique Hopitaux de Marseille - Hôpital Timone Enfants
  • Centre Hospitalier Universitaire de Montpellier - Hôpital Lapeyronie

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Cutaneous suture with glue

Conventional suture

Arm Description

Inguinal surgical incision closing using Dermabond® glue instead of cutaneous suture with surjet

Inguinal surgical incision closing with conventional cutaneous suture (surjet)

Outcomes

Primary Outcome Measures

Adequate or suboptimal wound-healing rate defined by a HOLLANDER cosmetic score higher or equal to 5 at the end of the initial wound-healing period.

Secondary Outcome Measures

Re-evaluation of the HOLLANDER cosmetic score 6 month after wound-healing.
Parental satisfaction: 0-100 numeric scale divided in 5 items.
Nurse satisfaction : 0-100 numeric scale divided in 4 items.

Full Information

First Posted
May 28, 2009
Last Updated
July 20, 2018
Sponsor
Centre Hospitalier Universitaire de Nice
Collaborators
Fondation Lenval, Centre Hospitalier Régional Universitaire Montpellier, Assistance Publique Hopitaux De Marseille
search

1. Study Identification

Unique Protocol Identification Number
NCT00909805
Brief Title
Interest of 2-octyl-cyanoacrylate (Dermabond®) in Closing Surgical Incisions in Children Before Acquisition of Continence
Official Title
Interest of 2-octyl-cyanoacrylate (Dermabond®) in Closing Surgical Incisions in Children Before Acquisition of Continence. Randomised, Prospective, Non-inferiority Study.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
September 2009 (Actual)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
June 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Nice
Collaborators
Fondation Lenval, Centre Hospitalier Régional Universitaire Montpellier, Assistance Publique Hopitaux De Marseille

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Inguinal incisions are the most frequent incisions used in children before the acquisition of continence (180 incisions per year for the Pediatric Surgery Department in Nice CHU). However, healing of those wounds can be made hard because of soiling induced by urine and/or stool, which is unavoidable in case of wearing nappies. Nowadays, in order to overcome a possible contamination of the surgical wound, post-surgery wound dressing is protected by the application of a waterproof band aid (like Tegaderm®) during wound-healing (evaluated to a mean of 7 days). When the band aid is soiled, a nurse changes it, causing unpleasantness in low age children (whose epidermal fragility is well known), and sometimes parents worry. Moreover, those occlusive wound dressings avoid any control of the surgical wound during healing phase. At the end of the wound-healing time, wound dressings are removed, causing discomfort for children and necessity of a qualified nurse staff at visit times. Cutaneous use glues, introduced in surgery more than 10 years ago, allow making waterproof and transparent sutures, with a firmness equivalent to a 2/0 string suture (cutaneous suture in children is made with 5/0) and has its own local antiseptic properties. It does not need to be covered by any wound dressing during wound-healing phase. Moreover, cosmetic results for the 2-octyl-cyanoacrylate in the adult and children series (without any precise age distinction) seem to be equivalent to conventional sutures. Finally, its application goes with time saving (in preoperative and during wound-healing phase) and increases comfort for patients. The aim of this study is to evaluate the efficiency of cutaneous use glue Dermabond® (2-octyl-cyanoacrylate) in surgical inguinal incisions sutures in children before the acquisition of continence, by a non-inferiority randomized multicentric prospective study. Two patient groups will be studied, the sutures of one control group will be made with a conventional technique (intradermic surjet surgical suture), and one patient group will be sutured with 2-octyl-cyanoacrylate. The principal evaluation criteria is the suture quality (short- and long-term cosmetic aspect) evaluated by the surgeon. Two secondary criteria will be studied : Parental satisfaction Ease of clinical nursing management Each studied criteria will be evaluated by a numeric score.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inguinal Incisions
Keywords
dermabond glue, suture, children

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
89 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cutaneous suture with glue
Arm Type
Experimental
Arm Description
Inguinal surgical incision closing using Dermabond® glue instead of cutaneous suture with surjet
Arm Title
Conventional suture
Arm Type
Active Comparator
Arm Description
Inguinal surgical incision closing with conventional cutaneous suture (surjet)
Intervention Type
Device
Intervention Name(s)
cutaneous suture (Surjet)
Intervention Description
cutaneous surjet suture
Intervention Type
Device
Intervention Name(s)
2-octyl-cyanoacrylate (Dermabond® glue)
Other Intervention Name(s)
2-octyl-cyanoacrylate (Dermabond®)
Intervention Description
the cutaneous suture is made with glue only
Primary Outcome Measure Information:
Title
Adequate or suboptimal wound-healing rate defined by a HOLLANDER cosmetic score higher or equal to 5 at the end of the initial wound-healing period.
Time Frame
J7-J10 and J+ 6 month
Secondary Outcome Measure Information:
Title
Re-evaluation of the HOLLANDER cosmetic score 6 month after wound-healing.
Time Frame
J0, J7-J10 and J + 6 month
Title
Parental satisfaction: 0-100 numeric scale divided in 5 items.
Time Frame
J0, J7-J10 and J + 6 month
Title
Nurse satisfaction : 0-100 numeric scale divided in 4 items.
Time Frame
J0, J7-J10 and J + 6 month

10. Eligibility

Sex
All
Maximum Age & Unit of Time
24 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children less than 24 months old Continuous nappies wearing for non-acquisition of continence Need of a surgical intervention which entry way is an inguinal incision in the inguinal fold (POTTS incision) for the following indications: inguinal hernia testicular ectopy hydrocele chord cyst Surgical incision smaller than 5 cm Informed consent form signed by both parents or by the legal representative Patient affiliated to French national health and pensions organization Exclusion Criteria: Chronic or acute dermatological affection that can hamper wound-healing (atopic pathology, infectious pathology…) General affection that can hamper wound-healing (chronic denutrition) Cutaneous infection at the incision site Scar in the concerned region Medical history of wound-healing trouble Digestive pathology causing chronic or acute diarrhea Allergy to one of the used compounds (glue, string, wound dressing) Operative indication set in emergency with immediate surgery Non-acceptance of the protocol, refusal to participate to the study by one of the parents or the legal representative Impossibility of doing the follow up of the child, in accordance with the pre-established rules of the protocol
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean BREAUD, MD
Organizational Affiliation
Centre Hospitalier Universitaire de Nice
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet2
City
Nice
State/Province
Alpes Maritimes
ZIP/Postal Code
06000
Country
France
Facility Name
Fondation Lenval -Hôpital Pédiatrique
City
Nice
State/Province
Alpes Maritimes
ZIP/Postal Code
06000
Country
France
Facility Name
Assistance Publique Hopitaux de Marseille - Hôpital Timone Enfants
City
Marseille
State/Province
Bouches Du Rhône
ZIP/Postal Code
13000
Country
France
Facility Name
Centre Hospitalier Universitaire de Montpellier - Hôpital Lapeyronie
City
Montpellier
State/Province
Hérault
ZIP/Postal Code
34000
Country
France

12. IPD Sharing Statement

Learn more about this trial

Interest of 2-octyl-cyanoacrylate (Dermabond®) in Closing Surgical Incisions in Children Before Acquisition of Continence

We'll reach out to this number within 24 hrs